Clinical Trial Update: SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy [Phase 3]

View source ↗

Summary

Phase 3 SENECA trial evaluates first-line metastasis-directed radiotherapy (including primary and distant lesions in oligometastatic pancreatic cancer); the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Radiation Therapy, SBRT | Phase 3 | Status: ACTIVE_NOT_RECRUITING